Search by Drug Name or NDC

    NDC 60687-0319-21 Tolterodine Tartrate 2 mg/1 Details

    Tolterodine Tartrate 2 mg/1

    Tolterodine Tartrate is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Health Packaging. The primary component is TOLTERODINE TARTRATE.

    Product Information

    NDC 60687-0319
    Product ID 60687-319_026e33a3-2338-09d2-e063-6294a90a73f6
    Associated GPIs 54100060207020
    GCN Sequence Number 047328
    GCN Sequence Number Description tolterodine tartrate CAP ER 24H 2 MG ORAL
    HIC3 R1A
    HIC3 Description URINARY TRACT ANTISPASMODIC/ANTIINCONTINENCE AGENT
    GCN 12264
    HICL Sequence Number 018047
    HICL Sequence Number Description TOLTERODINE TARTRATE
    Brand/Generic Generic
    Proprietary Name Tolterodine Tartrate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tolterodine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 2
    Active Ingredient Units mg/1
    Substance Name TOLTERODINE TARTRATE
    Labeler Name American Health Packaging
    Pharmaceutical Class Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203016
    Listing Certified Through 2024-12-31

    Package

    NDC 60687-0319-21 (60687031921)

    NDC Package Code 60687-319-21
    Billing NDC 60687031921
    Package 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-319-21) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (60687-319-11)
    Marketing Start Date 2017-08-14
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.42249
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description TOLTERODINE TART ER 2 MG CAP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis